Corline Biomedical AB Overview
Latest PEG ratio for Corline Biomedical AB: 49.73 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow49.73
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, CLBIO.ST shows a PEG ratio of 49.73. That is above the Healthcare sector average of 11.77. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 11.77. Corline Biomedical AB is at 49.73, which is higher that average. That is roughly 322.4% above the sector mean. Use the comparison chart on this page to see how CLBIO.ST stacks up against individual peers as well.
Investors watch CLBIO.ST's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Corline Biomedical AB's latest reading is 49.73. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Corline Biomedical AB's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 49.73) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 11.77, while CLBIO.ST is at 49.73. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
